StockData
Novartis AG logo

Novartis AG

NVSNYSEPharmaceutical PreparationsFiscal year ends December 31Also trades as NVSEF
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 20-F on Feb 4, 2026Score 7/30
$160.79−0.31 (-0.19%)

Close on Oct 30, 2026Market cap $306.81BP/E 22.5Yield –

Novartis 5. Established Brands & Contract Manufacturing by Quarter

5. Established Brands & Contract Manufacturing ($M)

QuarterlyAnnual

Novartis 5. Established Brands & Contract Manufacturing: $3,287M in Q3 2026, down 13.5% from a year earlier.

Latest, Q3 2026
3,287
Period ended Sep 30, 2026
Change on a year earlier
-13.5%
3,802 in Q3 2025
History
16 quarters
Since Q4 2022
Sources
12
Documents cited below

Where the Q3 2026 figure comes from

“|| Total established brands 4 | 3 287 | 3 802 | – 14 | – 14”

Source: Novartis Form 6-K (0001114448-26-000014) ↗

Reported in Form 6-K (Net sales by therapeutic area) & Form 20-F.

Quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEnded5. Established Brands & Contract Manufacturing ($M)Year on yearSource
Q3 2026Sep 30, 20263,287-13.5%Novartis Form 6-K (0001114448-26-000014) ↗
Q2 2026Jun 30, 20263,548-12.2%Novartis Form 6-K (0001114448-26-000012) ↗
Q1 2026Mar 31, 20263,292-20.1%Novartis Form 6-K (0001114448-26-000010) ↗
Q4 2025Dec 31, 20253,130-3.0%Novartis Form 6-K (0001114448-26-000007) ↗
Q3 2025Sep 30, 20253,802+14.2%Novartis Form 6-K (0001114448-26-000014) ↗
Q2 2025Jun 30, 20254,040+20.3%Novartis Form 6-K (0001114448-26-000012) ↗
Q1 2025Mar 31, 20254,121+18.2%Novartis Form 6-K (0001114448-26-000010) ↗
Q4 2024Dec 31, 20243,226-1.2%Novartis Form 6-K (0001114448-26-000007) ↗
Q3 2024Sep 30, 20243,330-13.6%Novartis Form 6-K (0001114448-25-000003) ↗
Q2 2024Jun 30, 20243,359-11.3%Novartis Form 6-K (0001370368-25-000012) ↗
Q1 2024Mar 31, 20243,486-9.2%Novartis Form 6-K (0001370368-25-000010) ↗
Q4 2023Dec 31, 20233,266-11.2%Novartis Form 6-K (0001370368-25-000007) ↗
Q3 2023Sep 30, 20233,856–Novartis Form 6-K (0001370368-24-000022) ↗
Q2 2023Jun 30, 20233,788–Novartis Form 6-K (0001370368-24-000019) ↗
Q1 2023Mar 31, 20233,839–Novartis Form 6-K (0001370368-24-000017) ↗
Q4 2022Dec 31, 20223,678–Novartis Form 6-K (0001370368-24-000007) ↗

Breakdown

What makes up 5. Established Brands & Contract Manufacturing

Cite this data

StockData. (2026). Novartis 5. Established Brands & Contract Manufacturing ($M), quarterly Q4 2022–Q3 2026 [Data set]. Compiled from Novartis SEC filings and investor materials. https://stockdatahq.com/stocks/nvs/kpis/ta-established

See every metric in the Novartis KPI table. Data updated Nov 2, 2026.